Total Payments
$782.60
2024 Payments
$24.56
Companies
2
Transactions
22
Medicare Patients
1,268
Medicare Billing
$143,780
Payment Breakdown by Category
Food & Beverage$782.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $782.60 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $559.16 | 20 | $0 (2024) |
| Novo Nordisk Inc | $223.44 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.56 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($24.56) |
| 2023 | $72.42 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($72.42) |
| 2022 | $212.76 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($212.76) |
| 2021 | $472.86 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($249.42) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Gastroenterology | ||||||
| 07/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Gastroenterology | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Gastroenterology | ||||||
| 03/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 02/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Gastroenterology | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Gastroenterology | ||||||
| 06/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Gastroenterology | ||||||
| 06/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Gastroenterology | ||||||
| 05/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $118.20 | General |
| Category: Gastroenterology | ||||||
| 02/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Gastroenterology | ||||||
| 01/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Gastroenterology | ||||||
| 12/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Gastroenterology | ||||||
| 12/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Gastroenterology | ||||||
| 11/19/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Gastroenterology | ||||||
| 11/19/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Gastroenterology | ||||||
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 10/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 06/24/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $98.44 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 274 | 339 | $192,989 | $32,665 |
| 2022 | 10 | 334 | 413 | $212,617 | $38,478 |
| 2021 | 11 | 402 | 497 | $200,343 | $43,579 |
| 2020 | 6 | 258 | 351 | $149,553 | $29,058 |
Total Patients
1,268
Total Services
1,600
Medicare Billing
$143,780
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 82 | $80,744 | $12,115 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 89 | $61,321 | $9,186 | 15.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $25,470 | $6,729 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 25 | $12,478 | $1,801 | 14.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 20 | $4,200 | $1,435 | 34.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 24 | $2,568 | $857.52 | 33.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 43 | $5,977 | $494.99 | 8.3% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 11 | 11 | $231.00 | $47.19 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 69 | $67,551 | $11,476 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 104 | $71,656 | $11,021 | 15.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $26,602 | $7,354 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 56 | $27,664 | $4,069 | 14.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 22 | $4,312 | $1,501 | 34.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 15 | $6,075 | $1,482 | 24.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 25 | $2,675 | $887.94 | 33.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 33 | 35 | $4,865 | $470.09 | 9.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 27 | 27 | $567.00 | $116.54 | 20.6% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2022 | 12 | 13 | $650.00 | $100.82 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 117 | $56,097 | $12,679 | 22.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 61 | $39,657 | $10,234 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $31,130 | $8,873 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 77 | $29,491 | $6,421 | 21.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 24 | $4,392 | $1,566 | 35.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $21,552 | $1,109 | 5.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 12 | $4,860 | $1,019 | 21.0% |
About Michele Belding, FACP, MD
Michele Belding, FACP, MD is a Gastroenterology healthcare provider based in Elmhurst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265439194.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Belding, FACP, MD has received a total of $782.60 in payments from pharmaceutical and medical device companies, with $24.56 received in 2024. These payments were reported across 22 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($782.60).
As a Medicare-enrolled provider, Belding has provided services to 1,268 Medicare beneficiaries, totaling 1,600 services with total Medicare billing of $143,780. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Elmhurst, NY
- Active Since 07/07/2005
- Last Updated 06/13/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265439194
Products in Payments
- XIFAXAN (Drug) $502.94
- Ozempic (Drug) $223.44
- TRULANCE (Drug) $56.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Elmhurst
Raghav Bansal
Gastroenterology — Payments: $67,414
Gastroenterology $67,414
Ashish Arora, Md, MD
Gastroenterology — Payments: $25,215
Gastroenterology $25,215
Dr. Chuansheng Wang, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $9,096
Gastroenterology $9,096
Igal Khorshidi, M.d, M.D
Gastroenterology — Payments: $2,991
Gastroenterology $2,991
Mr. Christopher Boutin, Md, MD
Gastroenterology — Payments: $2,011
Gastroenterology $2,011
Dr. Karen Ma, Md, Pharmd, MD, PHARMD
Gastroenterology — Payments: $1,858
Gastroenterology $1,858